GGrantIndex
← Leaderboards

Zhuo Zhang

University Of Kentucky

$5,665,815
Attributed
$8,851,747
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY201019
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$8,851,747 · 9

By mechanism

R01$8,299,327 · 7
R21$408,375 · 1
R03$144,045 · 1

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Others in their field

Top investigators on “Tumorigenesis

Research focus

TumorigenesisCarcinogenesisReactive Oxygen SpeciesGenerationsProteinsCellsTumorPathway InteractionsAntioxidantsCell TransformationEpithelialExhibitsMediatingOxidative StressIn VivoCarcinogenicityApoptosisChromium Hexavalent IonMalignant NeoplasmsSignal TransductionBcl2 GeneExposure ToAnimal ModelPlay

Grant awards (26)

Oxidative stress, Cr(VI) carcinogenesis, and prevention$728,875
R01 · FY2019 · ES
Role of Autophagy in Cd(II) Carcinogenesis$344,250
R01 · FY2019 · ES · contact PI
The role of p62 in the mechanism of Cr(VI) carcinogenesis$344,250
R01 · FY2019 · ES · contact PI
Oxidative stress, Cr(VI) carcinogenesis, and prevention$728,875
R01 · FY2018 · ES
Targeting p62 as a more optimal approach to inhibit autophagy using verteporfin as a repurposed therapeutic in prostate cancer$349,988
R01 · FY2018 · CA · contact PI
Role of Autophagy in Cd(II) Carcinogenesis$344,250
R01 · FY2018 · ES · contact PI
ROS and Nrf2 in arsenic carcinogenesis$344,250
R01 · FY2018 · ES · contact PI
Apoptosis resistance and Cr(VI) carcinogenesis$338,625
R01 · FY2018 · ES · contact PI
Oxidative stress, Cr(VI) carcinogenesis, and prevention$415,500
R01 · FY2017 · ES
ROS and Nrf2 in arsenic carcinogenesis$344,250
R01 · FY2017 · ES · contact PI
Oxidative stress, Cr(VI) carcinogenesis, and prevention$338,625
R01 · FY2017 · ES
Apoptosis resistance and Cr(VI) carcinogenesis$338,625
R01 · FY2017 · ES · contact PI
Oxidative stress, Cr(VI) carcinogenesis, and prevention$338,625
R01 · FY2016 · ES
Apoptosis resistance and Cr(VI) carcinogenesis$338,625
R01 · FY2016 · ES · contact PI
Apoptosis resistance and Cr(VI) carcinogenesis$338,438
R01 · FY2015 · ES · contact PI
Oxidative stress, Cr(VI) carcinogenesis, and prevention$338,438
R01 · FY2015 · ES
Apoptosis resistance and Cr(VI) carcinogenesis$337,500
R01 · FY2014 · ES · contact PI
HIF-alphia in Cr(VI) carcinogenesis$327,477
R01 · FY2014 · ES · contact PI
HIF-alphia in Cr(VI) carcinogenesis$324,168
R01 · FY2013 · ES · contact PI
Apple peel extract inhibits Cr(VI)-induced lung cancer$69,795
R03 · FY2013 · CA · contact PI
HIF-alphia in Cr(VI) carcinogenesis$330,784
R01 · FY2012 · ES · contact PI
Quercitrin functions as an antioxidant and protects UV-induced carcinogenesis$185,625
R21 · FY2012 · ES · contact PI
Apple peel extract inhibits Cr(VI)-induced lung cancer$74,250
R03 · FY2012 · CA · contact PI
HIF-alphia in Cr(VI) carcinogenesis$330,784
R01 · FY2011 · ES · contact PI
Quercitrin functions as an antioxidant and protects UV-induced carcinogenesis$222,750
R21 · FY2011 · ES · contact PI
HIF-alphia in Cr(VI) carcinogenesis$334,125
R01 · FY2010 · ES · contact PI